<DOC>
	<DOCNO>NCT01089660</DOCNO>
	<brief_summary>This study design describe immunogenicity pandemic A/H1N1 influenza vaccine healthy adult give low vaccine dose similar group give full dose vaccine . The primary objective describe describe immune response inactivate , split-virion swine-origin A/H1N1 influenza vaccine without adjuvant .</brief_summary>
	<brief_title>A Study Immunogenicity Swine-origin A/H1N1 Influenza Vaccine Healthy Adults</brief_title>
	<detailed_description>All participant receive single dose study vaccine also monitor serious adverse event adverse event special interest occur Days 0 21 6 month post-vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Aged 18 60 year day inclusion Informed consent form sign date Able attend schedule visit comply trial procedure For woman childbearing potential , use effective method contraception least 4 week prior vaccination least 4 week vaccination Entitled national social security Exclusion Criteria : Known pregnancy , positive urine pregnancy test Currently breastfeed child Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede trial vaccination Planned participation another clinical trial present trial period Receipt vaccine 4 week precede trial vaccination Receipt blood bloodderived product past 3 month , might interfere assessment immune response Known suspect congenital acquired immunodeficiency ; receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) Selfreported seropositivity human immunodeficiency virus ( HIV ) , hepatitis B , hepatitis C Known systemic hypersensitivity vaccine component , history lifethreatening reaction vaccine use trial vaccine contain substance Selfreported thrombocytopenia , contraindicate intramuscular ( IM ) vaccination Bleeding disorder , receipt anticoagulant 3 week precede inclusion , contraindicate IM vaccination Deprived freedom administrative court order , emergency setting , hospitalize involuntarily Current alcohol abuse drug addiction might interfere ability comply trial procedure Chronic illness , opinion investigator , stage might interfere trial conduct completion Employee investigator study center , direct involvement propose study study direction investigator study center , well family member employee investigator Participant previously vaccinate A/H1N1 pandemic influenza vaccine vaccination campaign clinical trial Personal history influenza infection since May 2009 Febrile illness ( temperature ≥ 38.0°C ) moderate severe acute illness/infection day vaccination , accord Investigator judgment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Pandemic Flu</keyword>
	<keyword>Swine-origin Influenza</keyword>
	<keyword>Inactivated split-virion vaccine</keyword>
</DOC>